Epigenetics Market to Garner US$ 2611.57 MN, Globally, by 2025 at 13.6% CAGR: The Insight Partners – Digital Journal

The Epigenetics in healthcare market was valued at US$ 991.45 million in 2017 and it is projected to reach US$ 2,611.57 million by 2025; it is expected to grow at a CAGR of 13.6% from 2018 to 2025.

According The Insight Partners study on Epigenetics Market Forecast to 2025 COVID-19 Impact and Global Analysis by Product ,Technology, Application, End Users, The report highlights trends existing in the market, and drivers and hindrances pertaining to the market growth. The growth of the Epigenetics in healthcare market is attributed to the declining prices of sequencing, increasing prevalence of cancer and funds & grants provided by government bodies.

The study of heritable changes in gene expression that do not involve changes to the underlying DNA sequence is known as epigenetics. A single or multiple change in phenotype without a changing the genotype which results affects the cells that can read the genes.

Get Sample PDF Copy of Epigenetics Market at: https://www.theinsightpartners.com/sample/TIPRE00007157/

Market Insights

Growing Applications of Epigenetics in Healthcare to Drive Epigenetics in Healthcare Market Growth

The declining costs associated with different strategies and methods for sequencing supports to influence the scale and scope of almost all genomic research projects. The costs associated with DNA sequencing performed at the sequencing centers which is funded by the Institutes, has tracked by the National Human Genome Research Institute (NHGRI) for many years. This information has served as a key standard for establishing the DNA sequencing capacity and considering improvements in DNA sequencing technologies of the NHGRI Genome Sequencing Program (GSP).

In the recent years, next generation sequencing price have declined substantially. For instance, first whole human genome sequencing cost over US$3.7 billion in 2000 and took 13 years for the completion. However, the costs for the same in recent years has reduces to US$1,000 and the process requires less number of days. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. Major market players such as Illumina and Roche have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing.

Owing to factors such as advances in the field of genomics, development in different methods and strategies for sequencing, there is a notable decline in the cost of sequencing, that upsurge the growth of the market.

The study of epigenetic alterations in cancer, such as aberrant methylation and altered transcription factor binding, provide insights into tumorigenic pathways, which is located above the genetic code. The microarray and nextgeneration sequencing (NGS) technologies help to detect altered methylation patterns and other epigenetic changes in cancer. For this, Illumina works with the cancer epigenetics experts to ensure its array and NGS solutions to meet the rapidly growing needs of the field.It also includes the impact of the COVID-19 pandemic on the market across all the regions. The sexual wellness, by region, is segmented into North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and South and Central America (SAM).North America held the largest market share in 2021.

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns.

Download the Latest COVID-19 Analysis on Epigenetics Market Growth Research Report at: https://www.theinsightpartners.com/covid-analysis-sample/TIPHE100000971

In terms of product, the Epigenetics in healthcare market is segmented into reagents, kits, enzymes, instruments & consumables and bioinformatics tools. In 2017, the kits segment held a largest market share of 29.8% of the epigenetics market, by product. This segment is also expected to dominate the market in 2025 owing to availability of several kits in the market for the gene expression analysis such as MicroRNA analysis, SNP genotyping analysis and other procedures.

Based on technology, the Epigenetics in healthcare market is segmented into histone modification, dna methylation and others. In 2017, the DNA methylation segment held a largest market share of 51.1% of the epigenetics market, by technology. This segment is also expected to dominate the market in 2025 as the technology mechanistic change in genomic conformation sets out a platform for various cellular processes, such as the exposure of the promoter of a specific gene to its transcriptional machinery.

In terms of application, the Epigenetics in healthcare market is segmented oncology, cardiovascular diseases and others. Oncology segment is anticipated to grow at a CAGR of 13.6% during the forecast period. The epigenetics offers prodigious potential for the identification of biomarkers that can be used to detect and diagnose cancer in its earliest stages.

In terms of end user, the Epigenetics in healthcare market is segmented into academic & research institutes, biotechnology & pharmaceutical companies, and contract research organization. In 2017, the pharmaceuticals & biotechnological companies segment held a largest market share of 61.2% of the epigenetics market, by end user. This segment is also expected to dominate the market in 2025.

Epigenetics Market: Competitive Landscape and Key Developments

Merck KGaA,Thermo Fisher Scientific Inc.,ABCAM Plc,Agilent Technologies,Active Motif,Qiagen,Bio-Rad Laboratories, Inc.,Perkinelmer Inc.,New England Biolabs (NEB),Illumina Inc.

Order a Copy of Epigenetics Market Shares, Strategies and Forecasts 2021-2025 Research Report athttps://www.theinsightpartners.com/buy/TIPHE100000971/

The Epigenetics in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person:Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone:+1-646-491-9876

Press Release: https://www.theinsightpartners.com/pr/epigenetics-market/

Read more:
Epigenetics Market to Garner US$ 2611.57 MN, Globally, by 2025 at 13.6% CAGR: The Insight Partners - Digital Journal